University of Patras
Μεταβολές των Τ κυτταρικών υποπληθυσμών μετά από θεραπεία με check point inhibitors
Abstract
dc:descriptionThe present study aims to explore the potential role of circulating lymphocytic subpopulations (T and Natural Killer) as biomarkers for response to checkpoint inhibitor (CPI) immunotherapy or for stratifying patients at high risk of developing immune-related adverse events. Twenty-one patients who were about to start treatment with a CPI (14 received nivolumab and 7 received pembrolizumab at standard doses) and eight healthy donors were enrolled. Peripheral blood mononuclear cells were obtained for flow cytometric analysis at five consecutive time points, pre- and post- treatment (up to six months). Total CD4+ lymphocytes were significantly decreased, whereas T helper 17 and regulatory T lymphocytes were significantly increased within non-Responders compared to healthy donors at treatment onset, indicating their potential significance for predicting non-response to anti-PD-1 immunotherapy. However, further validation is required.
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 2024
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Salamaliki, Christina
- Σαλαμαλίκη, Χριστίνα
Subjects
dc:subject × 16Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/57879